Cargando…

Impact of Vitamin D on Chronic Kidney Diseases in Non-Dialysis Patients: A Meta-Analysis of Randomized Controlled Trials

BACKGROUND AND OBJECTIVES: Recent studies have supported a role for both newer and more established vitamin D compounds in improving proteinuria, although systematic evaluation is lacking. Furthermore, concerns remain regarding the influence of vitamin D on the progression of renal function. We anal...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Lijuan, Wan, Xuesi, Huang, Zhimin, Zeng, Fangfang, Wei, Guohong, Fang, Donghong, Deng, Wanping, Li, Yanbing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3634086/
https://www.ncbi.nlm.nih.gov/pubmed/23626678
http://dx.doi.org/10.1371/journal.pone.0061387
_version_ 1782267055333965824
author Xu, Lijuan
Wan, Xuesi
Huang, Zhimin
Zeng, Fangfang
Wei, Guohong
Fang, Donghong
Deng, Wanping
Li, Yanbing
author_facet Xu, Lijuan
Wan, Xuesi
Huang, Zhimin
Zeng, Fangfang
Wei, Guohong
Fang, Donghong
Deng, Wanping
Li, Yanbing
author_sort Xu, Lijuan
collection PubMed
description BACKGROUND AND OBJECTIVES: Recent studies have supported a role for both newer and more established vitamin D compounds in improving proteinuria, although systematic evaluation is lacking. Furthermore, concerns remain regarding the influence of vitamin D on the progression of renal function. We analyzed the efficacy and safety of vitamin D in non-dialysis patients and compared the use of newer versus established vitamin D compounds by performing a meta-analysis of randomized controlled trials. DESIGN: A literature search of PubMed (1975 to September, 2012), EMBASE.com (1966 to September, 2012) and Ovid EBM Reviews (through September, 2012) was conducted. RESULTS: Eighteen studies were eligible for final inclusion; of these, six explored the effects of vitamin D on proteinuria, twelve studied the effects of supplementation on renal function, and fifteen discussed the incidence of hypercalcemia. Compared to the placebo or no interference, both the newer and established vitamin D sterols reduced proteinuria to a similar extent (RR, 2.00; 95% CI, 1.42 to 2.81). No decrease in the glomerular filter rate was observed (SMD, −0.10; 95%CI, −0.24 to 0.03), and the risk for dialysis initiation was 1.48 (95% CI, 0.54 to 4.03) with vitamin D treatment. Additionally, there was an increased risk of hypercalcemia for patients treated with either newer or established vitamin D compounds as compared with the controls (RR, 4.78; 95% CI, 2.20 to 10.37). The head-to-head studies showed no differences in the effects of either newer or established compounds on proteinuria or the risk of hypercalcemia. No serious adverse events were associated with the administration of vitamin D. CONCLUSIONS: Vitamin D therapy appears to decrease proteinuria and have no negative influence on renal function in non-dialysis patients. But the occurrence of hypercalcemia should be evaluated when vitamin D is provided. No superiority for newer versus established vitamin D analogue is found.
format Online
Article
Text
id pubmed-3634086
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-36340862013-04-26 Impact of Vitamin D on Chronic Kidney Diseases in Non-Dialysis Patients: A Meta-Analysis of Randomized Controlled Trials Xu, Lijuan Wan, Xuesi Huang, Zhimin Zeng, Fangfang Wei, Guohong Fang, Donghong Deng, Wanping Li, Yanbing PLoS One Research Article BACKGROUND AND OBJECTIVES: Recent studies have supported a role for both newer and more established vitamin D compounds in improving proteinuria, although systematic evaluation is lacking. Furthermore, concerns remain regarding the influence of vitamin D on the progression of renal function. We analyzed the efficacy and safety of vitamin D in non-dialysis patients and compared the use of newer versus established vitamin D compounds by performing a meta-analysis of randomized controlled trials. DESIGN: A literature search of PubMed (1975 to September, 2012), EMBASE.com (1966 to September, 2012) and Ovid EBM Reviews (through September, 2012) was conducted. RESULTS: Eighteen studies were eligible for final inclusion; of these, six explored the effects of vitamin D on proteinuria, twelve studied the effects of supplementation on renal function, and fifteen discussed the incidence of hypercalcemia. Compared to the placebo or no interference, both the newer and established vitamin D sterols reduced proteinuria to a similar extent (RR, 2.00; 95% CI, 1.42 to 2.81). No decrease in the glomerular filter rate was observed (SMD, −0.10; 95%CI, −0.24 to 0.03), and the risk for dialysis initiation was 1.48 (95% CI, 0.54 to 4.03) with vitamin D treatment. Additionally, there was an increased risk of hypercalcemia for patients treated with either newer or established vitamin D compounds as compared with the controls (RR, 4.78; 95% CI, 2.20 to 10.37). The head-to-head studies showed no differences in the effects of either newer or established compounds on proteinuria or the risk of hypercalcemia. No serious adverse events were associated with the administration of vitamin D. CONCLUSIONS: Vitamin D therapy appears to decrease proteinuria and have no negative influence on renal function in non-dialysis patients. But the occurrence of hypercalcemia should be evaluated when vitamin D is provided. No superiority for newer versus established vitamin D analogue is found. Public Library of Science 2013-04-23 /pmc/articles/PMC3634086/ /pubmed/23626678 http://dx.doi.org/10.1371/journal.pone.0061387 Text en © 2013 Xu et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Xu, Lijuan
Wan, Xuesi
Huang, Zhimin
Zeng, Fangfang
Wei, Guohong
Fang, Donghong
Deng, Wanping
Li, Yanbing
Impact of Vitamin D on Chronic Kidney Diseases in Non-Dialysis Patients: A Meta-Analysis of Randomized Controlled Trials
title Impact of Vitamin D on Chronic Kidney Diseases in Non-Dialysis Patients: A Meta-Analysis of Randomized Controlled Trials
title_full Impact of Vitamin D on Chronic Kidney Diseases in Non-Dialysis Patients: A Meta-Analysis of Randomized Controlled Trials
title_fullStr Impact of Vitamin D on Chronic Kidney Diseases in Non-Dialysis Patients: A Meta-Analysis of Randomized Controlled Trials
title_full_unstemmed Impact of Vitamin D on Chronic Kidney Diseases in Non-Dialysis Patients: A Meta-Analysis of Randomized Controlled Trials
title_short Impact of Vitamin D on Chronic Kidney Diseases in Non-Dialysis Patients: A Meta-Analysis of Randomized Controlled Trials
title_sort impact of vitamin d on chronic kidney diseases in non-dialysis patients: a meta-analysis of randomized controlled trials
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3634086/
https://www.ncbi.nlm.nih.gov/pubmed/23626678
http://dx.doi.org/10.1371/journal.pone.0061387
work_keys_str_mv AT xulijuan impactofvitamindonchronickidneydiseasesinnondialysispatientsametaanalysisofrandomizedcontrolledtrials
AT wanxuesi impactofvitamindonchronickidneydiseasesinnondialysispatientsametaanalysisofrandomizedcontrolledtrials
AT huangzhimin impactofvitamindonchronickidneydiseasesinnondialysispatientsametaanalysisofrandomizedcontrolledtrials
AT zengfangfang impactofvitamindonchronickidneydiseasesinnondialysispatientsametaanalysisofrandomizedcontrolledtrials
AT weiguohong impactofvitamindonchronickidneydiseasesinnondialysispatientsametaanalysisofrandomizedcontrolledtrials
AT fangdonghong impactofvitamindonchronickidneydiseasesinnondialysispatientsametaanalysisofrandomizedcontrolledtrials
AT dengwanping impactofvitamindonchronickidneydiseasesinnondialysispatientsametaanalysisofrandomizedcontrolledtrials
AT liyanbing impactofvitamindonchronickidneydiseasesinnondialysispatientsametaanalysisofrandomizedcontrolledtrials